|
OUR OCTOBER PEDIATRIC DERMATOLOGY ISSUE IS LIVE
Dr. Elaine Siegfried, Dermatology Times Editorial Advisor, introduces our pediatric issue with her editorial on the unique challenges facing children. Therapeutics is one of the most significant challenges in pediatric dermatology, she notes. There are few therapeutic options with FDA-approved pediatric indications. Access to new and novel treatments like biologics is especially limited.
» Will supportive legislation mark the dawn of a new era?
|
ADVERTISEMENT
Understanding the Psoriasis Patient
For information on psoriasis management, read the supplement Understanding the Psoriasis Patient: A Practical Approach to Patient Care at
 www.modernmedicine.com/psoriasis.
|
|
Researchers have found that many children do not present with conventional ABCDE criteria. Their lesions tend to be characterized by amelanosis, bleeding bumps, uniform color, variable diameter, and de novo development.
» How to recognize pediatric skin cancers
|
|
It's advisable for clinicians to release the fluid in blisters that develop in children with epidermolysis bullosa (EB), but they should aim to keep the roof of the blister intact, an expert recommend.
» Expert advises to reduce total bioburden
|
|
The diagnosis of angiokeratoma circumscriptum should be supplanted with verrucous hemangioma, and the lesion should be treated with surgery in most cases, according to a retrospective case series presented at the annual meeting of the Canadian Dermatology Association. » Read More
|
|
Read or listen to parts 3 and 4 in our series on medication adherence. Dr. Elaine Siegfried and Dr. Steven Feldman discuss patient satisfaction surveys, developing patient accountability, clinical trial results versus real life, and whole health system incentives for focusing more research in this area.
» Check out the full series
|
|
|
Like
Tweet
